{"id":2911,"date":"2016-11-22T21:58:53","date_gmt":"2016-11-22T21:58:53","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=18425"},"modified":"2016-11-22T21:58:53","modified_gmt":"2016-11-22T21:58:53","slug":"axim-biotechnologies-inc-donates-flagship-canchew-gum-u-s-pain-foundation-help-chronic-pain-sufferers","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/11\/22\/axim-biotechnologies-inc-donates-flagship-canchew-gum-u-s-pain-foundation-help-chronic-pain-sufferers\/","title":{"rendered":"Axim\u00ae Biotechnologies, Inc. Donates Flagship CanChew Gum to U.S. Pain Foundation to Help Chronic Pain Sufferers"},"content":{"rendered":"

NEW YORK, Nov. 22, 2016 (GLOBE NEWSWIRE) — AXIM\u00ae<\/sup>Biotechnologies, Inc. (AXIM\u00ae<\/sup> Biotech<\/a>) (OTC:AXIM<\/a>), a world leader in cannabinoid research and development, today announced that it has donated 3,200 pieces of its hemp-derived CBD functional chewing gum CanChew<\/a>\u00ae<\/sup> to the U.S. Pain Foundation to support the organization’s dedication in empowering caregivers and those who suffer from chronic pain.<\/p>\n

The U.S. Pain Foundation is a non-profit organization that educates, connects, informs and empowers those living with chronic pain, while also advocating on behalf of the pain community. While AXIM\u00ae<\/sup> Biotech<\/a>\u00a0makes no claims that its nutraceutical product CanChew<\/a>\u00ae<\/sup> gum can treat any specific condition, the positive effects of cannabidiol (CBD) for chronic pain sufferers is well established by science today.<\/p>\n

“We are honored to support an organization that dedicates itself to helping those with chronic pain, a national epidemic that affects nearly 100 million Americans,” said George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM\u00ae<\/sup> Biotechnologies. “Like the U.S. Pain Foundation, AXIM also believes in making an impact on individuals’ well-being, which we do through products that treat conditions for which there is currently no effective remedy.”<\/p>\n

CanChew\u00ae<\/sup> is the world’s first patented controlled-release cannabinoid chewing gum containing 50 mg of hemp oil and 10 mg of cannabidiol (CBD). AXIM\u00ae<\/sup> Biotech<\/a> holds the exclusive rights to market and distribute CanChew\u00ae<\/sup> Gum globally. CanChew<\/a>\u00ae<\/sup> is a hemp CBD chewing gum with a unique oral mucosal absorbance delivery system. Features listed on the CanChew<\/a>\u00ae<\/sup> website include:<\/p>\n